Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(21 sites)
France
CHU Clermont-Ferrand, Clermont-Ferrand CHU Dijon-Bourgogne, Dijon HCL - Groupement Hospitalier Est, Hôpital Femme Mère Enfant, Lyon AP-HM Hôpital de la Conception, Marseille AP-HM Hôpital Nord, Marseille CHU Montpellier, Montpellier Groupe hospitalier St Joseph, Paris Hôpital Armand - Trousseau, Paris CHI Poissy Saint Germain en Laye, Poissy CHU Saint Etienne, Hôpital Nord, Saint-Etienne CHU Strasbourg, Strasbourg Last updated January 2024